Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.
A report released today by the World Health Organization, United Nations Children’s Fund, and World Bank demonstrates the power of immunization to improve child and maternal health in the developing world. GHTC welcomes the report for highlighting the crucial role of vaccines in the progress that has been made to improve health around the world.
GHTC has received a three-year grant from the Bill & Melinda Gates Foundation to educate US policymakers about the benefits of new vaccines, microbicides, drugs, and diagnostics to improve health in developing countries.
In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.
The 140th session of the World Health Organization (WHO) Executive Board (EB) closed last week with a shortlist of three candidates for the WHO Director General position and progress on key global health R&D issues.